Adagio Therapeutics (ADGI)
NASDAQ:ADGI
US Market
Holding ADGI?
Track your performance easily

Adagio Therapeutics (ADGI) Income Statement

0 Followers

Adagio Therapeutics Income Statement

Last quarter (Q ), Adagio Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, Adagio Therapeutics's net income was $-50.99M. See Adagio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20
Total Revenue
-$ 0.00$ 0.00
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 292.00M$ 219.41M$ 25.20M
Operating Income
$ -292.00M$ -219.41M$ -25.20M
Net Non Operating Interest Income Expense
$ 48.00K-$ 8.00K
Other Income Expense
$ -3.04M$ -7.38M$ -40.12M
Pretax Income
$ -295.07M$ -226.79M$ -65.32M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -295.07M$ -226.79M$ -65.32M
Basic EPS
$ -3.13$ -5.32$ -1.03
Diluted EPS
$ -3.13$ -5.32$ -1.03
Basic Average Shares
$ 388.12M$ 42.62M$ 63.24M
Diluted Average Shares
$ 388.12M$ 42.62M$ 63.24M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 292.00M$ 219.41M$ 25.20M
Net Income From Continuing And Discontinued Operation
$ -295.07M$ -226.79M$ -65.32M
Normalized Income
$ -291.07M$ -219.29M$ -25.19M
Interest Expense
---
EBIT
$ -292.00M$ -219.41M$ -25.20M
EBITDA
$ -291.78M$ -219.41M$ -25.20M
Currency in USD

Adagio Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis